American Heart Journal American heart journal, 226, 60-68. Mosby Inc. American Heart Journal, 226, pp. 60-68 Gommans, D H F, Nas, J, Pinto-Sietsma, S J, Koop, Y, Konst, R E, Mensink, F, Aarts, G W A, Konijnenberg, L S F, Cortenbach, K, Verhaert, D V M, Thannhauser, J, Mol, J Q, Rooijakkers, M J P, Vos, J L, van Rumund, A, Vart, P, Hassing, R J, Cornel, J H, de Jager, C P C, van den Heuvel, M M, van der Hoeven, H G, Verbon, A, Pinto, Y M, van Royen, N, van Kimmenade, R R J, de Leeuw, P W, van Agtmael, M A, Bresser, P, van Gilst, W H, Vonk-Noordergraaf, A, Tijssen, J G P, Event committee, Data Safety Monitoring Board & Steering committee 2020, ' Rationale and design of the PRAETORIAN-COVID trial : A double-blind, placebo-controlled randomized clinical trial with valsartan for PRevention of Acute rEspiraTORy dIstress syndrome in hospitAlized patieNts with SARS-COV-2 Infection Disease: PRAETORIAN-COVID (NCT04335786) ', American Heart Journal, vol. 226, pp. 60-68 . https://doi.org/10.1016/j.ahj.2020.05.010 American Heart Journal, 226, 60-68. MOSBY-ELSEVIER American Heart Journal, 226, 60-68. Mosby Inc. American Heart Journal, 226, 60-68